Mira Mousa
- Co-authors
- Habiba AlsafarGuan K. TayPeter CarmelietLies FranssensHabiba Al SafarQun ZengDima AbdelmannanAhmed Hassoun
- Topics
- COVID-19 Clinical Research Studies (7 papers)SARS-CoV-2 and COVID-19 Research (6 papers)Angiogenesis and VEGF in Cancer (4 papers)
- Journals
- SHILAP Revista de lepidopterologíaNature reviews. CancerScientific Reports
- Partner nations
- United Arab EmiratesUnited KingdomAustralia
In The Last Decade
Mira Mousa
20 papers receiving 360 citations
Hit Papers
Peers
Comparison fields: 5 of 79
- Molecular Biology 132
- Infectious Diseases 107
- Immunology 54
- Oncology 51
- Cancer Research 51
Countries citing papers authored by Mira Mousa
This map shows the geographic impact of Mira Mousa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mira Mousa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mira Mousa more than expected).
Fields of papers citing papers by Mira Mousa
This network shows the impact of papers produced by Mira Mousa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mira Mousa. The network helps show where Mira Mousa may publish in the future.
Co-authorship network of co-authors of Mira Mousa
This figure shows the co-authorship network connecting the top 25 collaborators of Mira Mousa. A scholar is included among the top collaborators of Mira Mousa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mira Mousa. Mira Mousa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 11 | |
| 4 | 3 | |
| 5 | 5 | |
| 6 | 51 | |
| 7 | Understanding tumour endothelial cell heterogeneity and function from single-cell omicsbreakdown → | 101 |
| 8 | 4 | |
| 9 | 5 | |
| 10 | 25 | |
| 11 | 7 | |
| 12 | 4 | |
| 13 | 20 | |
| 14 | 19 | |
| 15 | 24 | |
| 16 | 22 | |
| 17 | 18 | |
| 18 | 6 | |
| 19 | 15 | |
| 20 | 23 |
About Mira Mousa
Mira Mousa is a scholar working on Infectious Diseases, Obstetrics and Gynecology and Health, having authored 20 papers that have together received 366 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (7 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and Angiogenesis and VEGF in Cancer (4 papers). The work is most often cited by research in Infectious Diseases (107 citations), Reproductive Medicine (39 citations) and Obstetrics and Gynecology (32 citations). Mira Mousa has collaborated with scholars based in United Arab Emirates, United Kingdom and Australia. Frequent co-authors include Habiba Alsafar, Guan K. Tay, Peter Carmeliet, Lies Franssens, Habiba Al Safar, Qun Zeng, Dima Abdelmannan, Ahmed Hassoun, Herbert F. Jelinek and Nawal Al Kaabi. Their work appears in journals such as SHILAP Revista de lepidopterología, Nature reviews. Cancer and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.